Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Incidence Study in Subtype B-Prevalent Region Among Men Who Have Sex With Men at Risk for Human Immunodeficiency Virus (HIV) Infection to Determine Feasibility of HIV Vaccine Efficacy Trials

NCT03884816 is registered in ClinicalTrials.gov with Hendrik Streeck as lead sponsor.

NCT NCT03884816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Incidence Study in Subtype B-Prevalent Region Among Men Who Have Sex With Men at Risk for Human Immunodeficiency Virus (HIV) Infection to Determine Feasibility of HIV Vaccine Efficacy Trials
Lead sponsor
Hendrik Streeck
Phase
Observational
Overall status
Completed
Start date
June 1, 2018
Completion date
March 22, 2021
Enrollment
1,017 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, risk reduction, sexual behavior